|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.55 EUR | 0.00% |
|
+37.50% | -54.17% |
| 2023 | Vitruvia Medical AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2022 | Vitruvia Medical AG announced that it expects to receive CHF 2.2 million in funding | CI |
Vitruvia Medical AG announced that it will issue convertible bonds for gross proceeds of CHF 2.2 million on November 26, 2022. The bonds will bear interest rate of 6% per annum and convertible into common shares of the company at a initial conversion rate of €2.50. The company will issue convertible bonds at par, at a price of 100%.
The transaction has been approved by the board of directors of the company. The bonds will have a term maturity expiring, 2025.
| 1st Jan change | Capi. | |
|---|---|---|
| -54.17% | 1.37M | |
| +5.92% | 32.61B | |
| +20.80% | 7.98B | |
| +25.15% | 3.99B | |
| -18.38% | 3.13B | |
| -19.61% | 1.38B | |
| -31.26% | 1.2B | |
| +8.02% | 959M | |
| -33.44% | 915M | |
| -26.12% | 819M |
VITRUVIA MEDICAL AG 